Share
Hemodialysis is a lifesaving procedure that requires a person to be connected to a dialysis machine by tubing that delivers fluid exchange. A vascular access is needed for this connection, with an arteriovenous fistula (AVF) or arteriovenous graft (AVG) being two common types of vascular access. AVFs and AVGs typically are surgically created in a patient’s arm but often require procedures to either become functional (during maturation phase) or maintain function after first use (maintenance phase). Using data from the United States Renal Data System (USRDS), our researchers calculated access procedure (intervention) rates in the US for patients starting hemodialysis with an AVF or AVG created during their first year of hemodialysis therapy between July 1, 2012 and December 31, 2014 (N = 73,027). Subsequent access-related procedures were included in analyses through Dec. 31, 2016. Interventions were common for both AVFs and AVGs as the access matured, with 13,989 of 57,275 (24.4%) AVFs requiring a procedure (0.36 AVF procedures/patient) and 2,904 of 15,572 (18.4%) AVG patients requiring intervention (0.28 AVG procedures/patient during maturation. However, during the maintenance phase, procedure rates were considerably lower for AVFs (0.93 procedures/patient occurring in 40% of patients) than for AVGs (1.87 procedures/patient occurring in 58% of patients). Thus, during maturation, interventions are carried out in 18-24% of newly created AVFs and AVGs. Once successfully matured, AVF had 50% lower maintenance interventional requirements.
The full text is available here: https://www.ajkd.org/article/S0272-6386(21)00511-4/fulltext
Citation
Woodside KJ, Repeck KJ, Mukhopadhyay P, Schaubel DE, Shahinian VB, Saran R, Pisoni RL. Arteriovenous Vascular Access-Related Procedural Burden Among Incident Hemodialysis Patients in the United States. Am J Kidney Dis. 2021 Apr 12:S0272-6386(21)00511-4. doi: 10.1053/j.ajkd.2021.01.019. Epub ahead of print. PMID: 33857533.
December 5, 2024 — Arbor Research Collaborative for Health is proud to announce an innovative collaboration with the Nephrology Associates of Northern Illinois and Indiana (NANI), the largest private nephrology practice in the United States. This partnership marks a significant milestone in advancing chronic kidney disease (CKD) research and management by leveraging NANI’s extensive patient-level […]
Arbor Research Collaborative for Health is excited to announce a partnership with CSL Vifor to launch a multinational registry designed to capture real-world outcomes of difelikefalin (Kapruvia®), a newly-approved treatment for chronic kidney disease-associated pruritus (CKD-aP) in hemodialysis (HD) patients. Known as PARADIGM (PAn european Registry Addressing pruritus in DIalysis with a focus on Goal […]
The Dialysis Outcomes and Practice Patterns Study (DOPPS) Program at Arbor Research Collaborative for Health is pleased to share their recent publication recognized as one of the most- downloaded articles at Kidney International Reports in the past few weeks titled “Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the […]
Arbor Research Collaborative for Health (Arbor Research) recently welcomed Dr. Ping Yu, as Chief Growth Officer. In his new role at Arbor Research, Dr. Yu will lead the Strategic Growth Team (SGT) to further expand Arbor Research’s growth initiatives. Dr. Yu brings a wealth of experience in health data, analytics, research, and evaluation, with a […]